Join William Gradishar, MD and Seema Khan, MD as they present their multidisciplinary expertise on a range of cases pertaining to hormone sensitive breast cancer.

This congress is an educational program that addresses health care professionals' need to be educated on current and emerging evidenced-based scientific data for accurate and timely clinical evaluation of patients with breast cancer, including the management of early stage and advanced disease.

Quality in oncology healthcare is a moving target for stakeholders (patients, healthcare providers, and payers) in systematically identifying, planning, and executing approaches to improving quality.

Managing breast cancer across the continuum of care, including early breast cancer, metastatic disease, and survivorship is a complex and rapidly evolving task.

Managing breast cancer across the continuum of care, including early breast cancer, metastatic disease, and survivorship is a complex and rapidly evolving task.

The 2013 Nursing Program: Advancing Oncology Nursing™ webinar series provides the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.

These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-postive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer.

Join Harold Burstein, MD, PhD (Medical Oncologist) and Jennifer Bellon, MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to triple negative breast cancer.

The phosphoinositide-3-kinase (PI3-kinase)-Akt-mTOR pathway is a central signal transduction pathway that regulates many critical aspects of normal and cancer physiology, including cell proliferation, apoptosis, cell morphology and migration, protein synthesis, and integration of metabolism.

Join Harold Burstein, MD, PhD (Medical Oncologist) and Jennifer Bellon, MD (Radiation Oncologist) as they present their multidisciplinary expertise on a range of cases pertaining to triple negative breast cancer.